13175-00-3

Basic information

• Product Name: 2-Methyl-2H-tetrazole-5-carboxylic acid
• Synonyms: 2-Methyl-2H-tetrazole-5-carboxylic acid
• CAS NO: 13175-00-3
• Molecular Formula: C₃H₄N₄O₂
• Molecular Weight: 128.08946
• Mol File: 13175-00-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 373.2°Cat760mmHg
• Flash Point: 179.5°C
• Appearance: /
• Density: 1.81g/cm³
• Vapor Pressure: 3.12E-06mmHg at 25°C
• Refractive Index: 1.737
• CAS DataBase Reference: 2-Methyl-2H-tetrazole-5-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methyl-2H-tetrazole-5-carboxylic acid(13175-00-3)
• EPA Substance Registry System: 2-Methyl-2H-tetrazole-5-carboxylic acid(13175-00-3)

Safety Data

• Hazardous Substances Data: 13175-00-3(Hazardous Substances Data)

Usage

General Description

2-Methyl-2H-tetrazole-5-carboxylic acid is a chemical compound categorized under the group of tetrazoles. It is an intermediate typically used for the synthesis of pharmaceuticals and other organic compounds, offering the potential for various applications in chemical and pharmaceutical industries. Like many other chemical substances, it needs to be handled with care due to its reactive nature. The compound carries an IUPAC name of 1-Methyl-1H-tetrazole-5-carboxylic acid and its CAS number is 28014-49-7. Despite being commonly used in the scientific and industrial sectors, detailed information about its physical and chemical properties is limited in public literature.

InChI:InChI=1/C3H4N4O2/c1-7-5-2(3(8)9)4-6-7/h1H3,(H,8,9)

Upstream product

• 91511-38-5 ethyl 2-methyl-2H-tetrazole-5-carboxylate 
• 74-88-4 methyl iodide 
• 91616-41-0 ethyl 1-methyl-1H-tetrazole-5-carboxylate 
• 55408-10-1 1H-tetrazole-5-carboxylic acid ethyl ester 
• 91511-39-6 2-methyl-2H-tetrazole-5-carbonitrile 

Downstream Products

• 96107-88-9 methyl 2-methyl-2H-tetrazole-5-carboxylate 
• 91511-38-5 ethyl 2-methyl-2H-tetrazole-5-carboxylate 
• 16681-78-0 2-methyltetrazole 
• 64591-58-8 (2-methyl-2H-tetrazol-5-yl)-phenyl-methanone 

Relevant articles and documents

-

-

DIHYDROBENZOFURAN AND INDEN ANALOGS AS CARDIAC SARCOMERE INHIBITORS

Provided are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R1, R2, R3, G1, G2, and G3 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof Also provided are methods of using a compound of Formula (I), or a pharmaceutically acceptable salt, thereof for use in methods of treatment heart diseases through cardiac sarcomere inhibtion.

HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS

A compound represented by the formula (I): wherein Z1,Z2,Z3 and Z4 are the following combination, (Z1,Z2,Z3,Z4)=(CR4,N,CR5,C), (N,N,CR5,C), (N,C,CR5,N), (S,C,CR5,C) or (S,C,N,C); R1 and R2 are the same or different and each is (1) a hydrogen atom, (2) a halogen atom, (3) a group bonded via a carbon atom, (4) a group bonded via a nitrogen atom, (5) a group bonded via an oxygen atom or (6) a group bonded via a sulfur atom; R 3 is an amino optionally having substituent(s); R4 and R 5 are the same or different and each is (1) a hydrogen atom, (2) a halogen atom, (3) a group bonded via a carbon atom, (4) a group bonded via a nitrogen atom, (5) a group bonded via an oxygen atom or (6) a group bonded via a sulfur atom; R3 and R4 optionally form a ring optionally having substituent(s); and a group represented by the formula (A) is a cyclic group optionally having substituent(s), or a salt thereof